Atrema therapeutics is a gene therapy company that treats rare hereditary vision diseases in order to normalize the quality of life not only for patients themselves, but also their loved ones.
We understand that genetic loss of vision is a great tragedy for patients, as well as their families. By creating gene therapy drugs that can stop vision loss in patients with congenital eye pathologies, we not only make the patients happier, but also help the people around them. Thus, by curing pathologies that affect the minority, we solve the problems of the majority.
Hereditary disease affects millions of people worldwide. We work to treat inherited rare diseases through gene therapy to save the vision of our patients, so that people with hereditary eye diseases can live full lives.